131 related articles for article (PubMed ID: 8891916)
21. Comparison of different immunoassays and GC-MS screening of benzodiazepines in urine.
Augsburger M; Rivier L; Mangin P
J Pharm Biomed Anal; 1998 Dec; 18(4-5):681-7. PubMed ID: 9919969
[TBL] [Abstract][Full Text] [Related]
22. Simultaneous quantification of urine flunitrazepam, nimetazepam and nitrazepam by using liquid chromatography tandem mass spectrometry.
Lee HH; Lee JF; Lin SY; Lin YY; Wu CF; Wu MT; Chen BH
Clin Chim Acta; 2013 May; 420():134-9. PubMed ID: 23085494
[TBL] [Abstract][Full Text] [Related]
23. Determination of the metabolites of gestrinone in human urine by high performance liquid chromatography, liquid chromatography/mass spectrometry and gas chromatography/mass spectrometry.
Kim Y; Lee Y; Kim M; Yim YH; Lee W
Rapid Commun Mass Spectrom; 2000; 14(18):1717-26. PubMed ID: 10962496
[TBL] [Abstract][Full Text] [Related]
24. Serum and urine concentrations of flunitrazepam and metabolites, after a single oral dose, by immunoassay and GC-MS.
Snyder H; Schwenzer KS; Pearlman R; McNally AJ; Tsilimidos M; Salamone SJ; Brenneisen R; ElSohly MA; Feng S
J Anal Toxicol; 2001; 25(8):699-704. PubMed ID: 11765027
[TBL] [Abstract][Full Text] [Related]
25. The decomposition of benzodiazepines during analysis by capillary gas chromatography/mass spectrometry.
Joyce JR; Bal TS; Ardrey RE; Stevens HM; Moffat AC
Biomed Mass Spectrom; 1984 Jun; 11(6):284-9. PubMed ID: 6743768
[TBL] [Abstract][Full Text] [Related]
26. Papain: a novel urine adulterant.
Burrows DL; Nicolaides A; Rice PJ; Dufforc M; Johnson DA; Ferslew KE
J Anal Toxicol; 2005; 29(5):275-95. PubMed ID: 16105251
[TBL] [Abstract][Full Text] [Related]
27. The application of HPLC to the determination of some 1,4 benzodiazepines and their metabolites in plasma.
Skellern GG; Meier J; Knight BI; Whiting B
Br J Clin Pharmacol; 1978 Jun; 5(6):483-7. PubMed ID: 656291
[TBL] [Abstract][Full Text] [Related]
28. Determination of benzodiazepines in clinical serum samples: comparative evaluation of REMEDi system, aca analyzer, and conventional HPLC performance.
Chang TL; Chen KW; Lee YD; Fan K
J Clin Lab Anal; 1999; 13(3):106-11. PubMed ID: 10323474
[TBL] [Abstract][Full Text] [Related]
29. Characterization and in vitro phase I microsomal metabolism of designer benzodiazepines: An update comprising flunitrazolam, norflurazepam, and 4'-chlorodiazepam (Ro5-4864).
Moosmann B; Bisel P; Westphal F; Wilde M; Kempf J; Angerer V; Auwärter V
Drug Test Anal; 2019 Mar; 11(3):541-549. PubMed ID: 30578721
[TBL] [Abstract][Full Text] [Related]
30. A validated method for simultaneous screening and quantification of twenty-three benzodiazepines and metabolites plus zopiclone and zaleplone in whole blood by liquid-liquid extraction and ultra-performance liquid chromatography- tandem mass spectrometry.
Simonsen KW; Hermansson S; Steentoft A; Linnet K
J Anal Toxicol; 2010; 34(6):332-41. PubMed ID: 20663286
[TBL] [Abstract][Full Text] [Related]
31. Highly sensitive micro-plate enzyme immunoassay screening and NCI-GC-MS confirmation of flunitrazepam and its major metabolite 7-aminoflunitrazepam in hair.
Negrusz A; Moore C; Deitermann D; Lewis D; Kaleciak K; Kronstrand R; Feeley B; Niedbala RS
J Anal Toxicol; 1999 Oct; 23(6):429-35. PubMed ID: 10517547
[TBL] [Abstract][Full Text] [Related]
32. Chromatography of benzodiazepines.
Sioufi A; Dubois JP
J Chromatogr; 1990 Oct; 531():459-80. PubMed ID: 1979564
[TBL] [Abstract][Full Text] [Related]
33. Comparison between drug screening by immunoassay and ultra-high performance liquid chromatography/high-resolution time-of-flight mass spectrometry in post-mortem urine.
Sundström M; Pelander A; Ojanperä I
Drug Test Anal; 2015 May; 7(5):420-7. PubMed ID: 24953563
[TBL] [Abstract][Full Text] [Related]
34. Kinetics and mechanisms of hydrolysis of 1,4-benzodiazepines I: chlordiazepoxide and demoxepam.
Han WW; Yakatan GJ; Maness DD
J Pharm Sci; 1976 Aug; 65(8):1198-204. PubMed ID: 10416
[TBL] [Abstract][Full Text] [Related]
35. Negative ion chemical ionization gas chromatography-mass spectrometry and atmospheric pressure chemical ionization liquid chromatography-mass spectrometry of low-dosed and/or polar drugs in plasma.
Maurer HH; Kraemer T; Kratzsch C; Peters FT; Weber AA
Ther Drug Monit; 2002 Feb; 24(1):117-24. PubMed ID: 11805732
[TBL] [Abstract][Full Text] [Related]
36. Determination of clobazam, N-desmethylclobazam and their hydroxy metabolites in plasma and urine by high-performance liquid chromatography.
Tomasini JL; Bun H; Coassolo P; Aubert C; Cano JP
J Chromatogr; 1985 Oct; 343(2):369-77. PubMed ID: 4066878
[TBL] [Abstract][Full Text] [Related]
37. Toxicological screening in urine: comparison of two automated HPLC screening systems, toxicological identification system (TOX.I.S.*) versus REMEDI-HS.
Schönberg L; Grobosch T; Lampe D; Kloft C
J Anal Toxicol; 2007; 31(6):321-7. PubMed ID: 17725877
[TBL] [Abstract][Full Text] [Related]
38. Characterization and evaluation of two-dimensional microfluidic chip-HPLC coupled to tandem mass spectrometry for quantitative analysis of 7-aminoflunitrazepam in human urine.
Bai HY; Lin SL; Chan SA; Fuh MR
Analyst; 2010 Oct; 135(10):2737-42. PubMed ID: 20820494
[TBL] [Abstract][Full Text] [Related]
39. Benzodiazepines identified by capillary gas chromatography-mass spectrometry, with specific ion screening used to detect benzophenone derivatives.
Jones CE; Wians FH; Martinez LA; Merritt GJ
Clin Chem; 1989 Jul; 35(7):1394-8. PubMed ID: 2667799
[TBL] [Abstract][Full Text] [Related]
40. Flunitrazepam excretion patterns using the Abuscreen OnTrak and OnLine immunoassays: comparison with GC-MS.
Salamone SJ; Honasoge S; Brenner C; McNally AJ; Passarelli J; Goc-Szkutnicka K; Brenneisen R; elSohly MA; Feng S
J Anal Toxicol; 1997 Sep; 21(5):341-5. PubMed ID: 9288585
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
